CVS Health Corp

CVS-N

NYSE:CVS

63.14
0.78 (1.22%)
CVS Health is an American retail pharmacy and health care company headquartered in Woonsocket, Rhode Island.
More at Wikipedia

Analysis and Opinions about CVS-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
June 29, 2020
He is surprised they did not do better going into this crisis. They are big in the healthcare management area. Buying a company like this in the US at these valuations is a very prudent move and he expects it to do very well over the coming years. (Analysts’ price target is $79.74)
Show full opinionHide full opinion
He is surprised they did not do better going into this crisis. They are big in the healthcare management area. Buying a company like this in the US at these valuations is a very prudent move and he expects it to do very well over the coming years. (Analysts’ price target is $79.74)
COMMENT
COMMENT
June 17, 2020

He has chosen to exit their holding about a year ago, based on their UK alliance (due to Brexit). He participates in the space with CVS instead, who bought a pharmacy benefits company. CVS has more than 10,000 locations in the US. The company has become vertically integrated, which gives them a long runway. Their "Health Hub" offers medical practitioners to people who would not otherwise have access to one.

Show full opinionHide full opinion

He has chosen to exit their holding about a year ago, based on their UK alliance (due to Brexit). He participates in the space with CVS instead, who bought a pharmacy benefits company. CVS has more than 10,000 locations in the US. The company has become vertically integrated, which gives them a long runway. Their "Health Hub" offers medical practitioners to people who would not otherwise have access to one.

PAST TOP PICK
PAST TOP PICK
May 12, 2020

(A Top Pick Apr 22/19, Up 25%) Undervalued at 9x PE, still likes it. This is the future of US healthcare where costs are 50% more than other western countries. A way to reduce this cost is through CVS, such as using their health hub technology instead of walking into emergency. CVS has been smart developing this business. CVS also gets a cheaper line of drugs and they recently bought Aetna. Altogether, CVS is vertically integrated. A great company.

Show full opinionHide full opinion

(A Top Pick Apr 22/19, Up 25%) Undervalued at 9x PE, still likes it. This is the future of US healthcare where costs are 50% more than other western countries. A way to reduce this cost is through CVS, such as using their health hub technology instead of walking into emergency. CVS has been smart developing this business. CVS also gets a cheaper line of drugs and they recently bought Aetna. Altogether, CVS is vertically integrated. A great company.

PAST TOP PICK
PAST TOP PICK
April 23, 2020
(A Top Pick May 03/19, Up 12%) It held in there nicely. It set back to its book value after a good run. He would still buy it.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
April 23, 2020
(A Top Pick May 03/19, Up 12%) It held in there nicely. It set back to its book value after a good run. He would still buy it.
DON'T BUY
DON'T BUY
April 7, 2020

Healthcare is one of the best three sectors over the last 50 years. Eli Lily is a better choice. He's not in drugstores, because they are cyclical, such as 2008-9 when they got hit in a slow economy. Drugstores make their money buying impulse items in addition to their drugs, and people don't buy in tough times. He suggest Costco which fulfills prescriptions, but sells groceries. And Amazon is getting into this space.

Show full opinionHide full opinion

Healthcare is one of the best three sectors over the last 50 years. Eli Lily is a better choice. He's not in drugstores, because they are cyclical, such as 2008-9 when they got hit in a slow economy. Drugstores make their money buying impulse items in addition to their drugs, and people don't buy in tough times. He suggest Costco which fulfills prescriptions, but sells groceries. And Amazon is getting into this space.

HOLD
HOLD
March 13, 2020
This has been hurt badly due to the virus. They had a good last quarter. She would continue to hold it. The risk of regulatory concern is lower too now that Biden looks like the likely Democrat candidate.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
March 13, 2020
This has been hurt badly due to the virus. They had a good last quarter. She would continue to hold it. The risk of regulatory concern is lower too now that Biden looks like the likely Democrat candidate.
PARTIAL BUY
PARTIAL BUY
March 11, 2020

There are two positives there for them. They are a drug distributor and they are now into healthcare insurance. With Sanders looking less likely to be the Democrat candidate, they should see some benefit. He is concerned there is a lot of competition out there for this space, like Costco, Walmart and others. Near term he could see a bottom coming in the share price and will be looking to pick away at it.

Show full opinionHide full opinion
CVS Health Corp (CVS-N)
March 11, 2020

There are two positives there for them. They are a drug distributor and they are now into healthcare insurance. With Sanders looking less likely to be the Democrat candidate, they should see some benefit. He is concerned there is a lot of competition out there for this space, like Costco, Walmart and others. Near term he could see a bottom coming in the share price and will be looking to pick away at it.

WAIT
WAIT
February 28, 2020
He had owned this a couple of years ago. He has favoured other health plays, but is watching this again. With Bernie Sanders rising in the Democratic leadership race, the threat to the pharma community is rising again. There is headline risk in this space. A share price drop of $5 might bring him in on this stock, but waiting is probably best.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
February 28, 2020
He had owned this a couple of years ago. He has favoured other health plays, but is watching this again. With Bernie Sanders rising in the Democratic leadership race, the threat to the pharma community is rising again. There is headline risk in this space. A share price drop of $5 might bring him in on this stock, but waiting is probably best.
TOP PICK
TOP PICK
February 26, 2020
An integrated health company, including insurance. This business model lets them add value to customers. There's some uncertainty about US healthcare reform which has hit CVS's valuation of 9x earnings with a 9% free cash flow yield. Amazing value. (Analysts’ price target is $84.08)
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
February 26, 2020
An integrated health company, including insurance. This business model lets them add value to customers. There's some uncertainty about US healthcare reform which has hit CVS's valuation of 9x earnings with a 9% free cash flow yield. Amazing value. (Analysts’ price target is $84.08)
TOP PICK
TOP PICK
February 20, 2020
Becoming a full health-care services company. It's all about scale. Paid down debt. Trades at 10x, cheap right now. Dividend may not grow for next couple of years. Yield is 2.78%. (Analysts’ price target is $84.04)
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
February 20, 2020
Becoming a full health-care services company. It's all about scale. Paid down debt. Trades at 10x, cheap right now. Dividend may not grow for next couple of years. Yield is 2.78%. (Analysts’ price target is $84.04)
BUY
BUY
February 10, 2020

The pharma retailers are becoming full-service, like Loblaw buying Shoppers Drug Mart. There's better growth in drugstore bricks and mortar retailing. Trades at a reasonable multiple. You're fine to hold this.

Show full opinionHide full opinion
CVS Health Corp (CVS-N)
February 10, 2020

The pharma retailers are becoming full-service, like Loblaw buying Shoppers Drug Mart. There's better growth in drugstore bricks and mortar retailing. Trades at a reasonable multiple. You're fine to hold this.

COMMENT
COMMENT
January 21, 2020
He likes this space. It's toppy now, with $80 as the top, a level it rarely breaks. Just be aware of that.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
January 21, 2020
He likes this space. It's toppy now, with $80 as the top, a level it rarely breaks. Just be aware of that.
DON'T BUY
DON'T BUY
January 17, 2020
He does not hold this currently. It is in the middle of the pack in terms of valuation metrics, especially since it holds a higher level of debt.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
January 17, 2020
He does not hold this currently. It is in the middle of the pack in terms of valuation metrics, especially since it holds a higher level of debt.
COMMENT
COMMENT
January 17, 2020
This hasn't been a name for them. They are focusing more on the retail side and he wants a more pure play on healthcare. They have developed their pharmacy benefit managers. At around 10x earnings, it's fairly inexpensive but their debt levels are fairly high. They are trying to vertically integrate.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
January 17, 2020
This hasn't been a name for them. They are focusing more on the retail side and he wants a more pure play on healthcare. They have developed their pharmacy benefit managers. At around 10x earnings, it's fairly inexpensive but their debt levels are fairly high. They are trying to vertically integrate.
HOLD
HOLD
January 16, 2020
It has had a great move since June. It is going to run into resistance in the high $70 range. He thinks you should focus on companies that get a boost from a stronger economy. We have come off a mid-cycle slow down. Earnings growth at CVS-N is in the single digits but less likely to get a boost from a stronger economy. He thinks it will under-perform the general market over the next year.
Show full opinionHide full opinion
CVS Health Corp (CVS-N)
January 16, 2020
It has had a great move since June. It is going to run into resistance in the high $70 range. He thinks you should focus on companies that get a boost from a stronger economy. We have come off a mid-cycle slow down. Earnings growth at CVS-N is in the single digits but less likely to get a boost from a stronger economy. He thinks it will under-perform the general market over the next year.
Showing 1 to 15 of 272 entries

CVS Health Corp(CVS-N) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 17

Neutral - Hold Signals / Votes : 3

Bearish - Sell Signals / Votes : 7

Total Signals / Votes : 27

Stockchase rating for CVS Health Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CVS Health Corp(CVS-N) Frequently Asked Questions

What is CVS Health Corp stock symbol?

CVS Health Corp is a American stock, trading under the symbol CVS-N on the New York Stock Exchange (CVS). It is usually referred to as NYSE:CVS or CVS-N

Is CVS Health Corp a buy or a sell?

In the last year, 27 stock analysts published opinions about CVS-N. 17 analysts recommended to BUY the stock. 7 analysts recommended to SELL the stock. The latest stock analyst recommendation is TOP PICK. Read the latest stock experts' ratings for CVS Health Corp.

Is CVS Health Corp a good investment or a top pick?

CVS Health Corp was recommended as a Top Pick by Michael Sprung on 2020-06-29. Read the latest stock experts ratings for CVS Health Corp.

Why is CVS Health Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CVS Health Corp worth watching?

27 stock analysts on Stockchase covered CVS Health Corp In the last year. It is a trending stock that is worth watching.

What is CVS Health Corp stock price?

On 2020-07-08, CVS Health Corp (CVS-N) stock closed at a price of $63.14.